In this study, we found that CITCO promotes CHOP-mediated attenuation of cell proliferation markers and augmentation of the expression of cleaved caspase-3 in treated EL-4 xenografts, further elaborating the therapeutic benefits of concomitant use of CITCO with CHOP in lymphoma chemotherapy. This evidence concerns the gene DDIT3 and lymphoma.